0NOF

Procter & Gamble Company

Common Stock · USD · NYSE

PGT212

Price

$146.18

-0.96%

Cap

Earnings

30d Trend

-1.4%

0NOF
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityModerate

22% annualised over 90 days

Next earnings:2026-07-29

BRAIN47 SIGNAL

0
STRONG
Risk Level30
Quality78
Momentum41
Technical55
Fundamentals55

Raw weighted: 59×Macro 0.99 (1%)=58

RISK

30/100
90d Volatility
22.3%Moderate
ATR %
1.9%Normal
Max Drawdown (1Y)
-19.2%Normal

QUALITY

78/100
ROE (avg)
31.1%Excellent
Piotroski F-Score
6/9Average
Debt/Equity
0.68Moderate
Margin Stability
CV 4.0%Very stable
Accruals
-1.5%Cash earnings
Interest Coverage
22.5xVery comfortable

MOMENTUM

41/100
12-1M Momentum
-13.0%Strong downtrend
6-1M Momentum
-0.7%Flat
1M Return
-0.1%Stable

TECHNICAL

55/100
RSI (14)
52.6Neutral
Price vs SMA200
-1.4%Flat
MACD
+0.38Bullish momentum
Bollinger Band
73%Mid-range
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.004Noisy/choppy

FUNDAMENTALS

55/100
EV/EBIT
15.5Fair
P/FCF
20.8Fair
P/S
3.4Fair
PEG
4.10Overpriced growth
Shareholder Yield
5.6%Strong returns

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months45
3-12 months34
1-5+ years62

Long-term compounder with 5.6% yield

BRAIN47'S ASSESSMENT

I rate Procter & Gamble Company at 58/100 — a STRONG reading on the Brain47 Signal. The strongest factor is quality at 78/100. I classify this as a income position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

-0.1%

3 MONTHS

-10.3%

12 MONTHS

-13.1%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Long-term compounder with 5.6% yield. Quality (78) and low-risk profile are the primary strengths. I note that momentum is the weakest area at 41/100 — this warrants monitoring. Historical volatility is normal at 22%. I classify this as an income position — the 5.6% yield combined with the dividend profile makes it suitable for income generation.

incomeScore: 58/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.